首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drug metabolism reviews

缩写:DRUG METAB REV

ISSN:0360-2532

e-ISSN:1097-9883

IF/分区:3.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引519
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Bin Ma,Lionel Cheruzel,Sungjoon Cho et al. Bin Ma et al.
New drug modalities (NDMs) continue to redefine the pharmaceutical landscape by addressing "undruggable" targets and providing innovative therapeutics for various diseases. This third annual review summarizes 15 selected publications from 2...
F Peter Guengerich F Peter Guengerich
Kinetic isotope effects (KIEs) have been used to study mechanisms of cytochrome P450 (P450, CYP) reactions and are the basis of most applications for deuterated drugs. However, the complexity of KIEs has led to limited use and to some erron...
Harshal Ahirrao,Hemant Kumar Tatapudi,Kishore Raju Vatsavai Harshal Ahirrao
Cyclophosphamide (CP) is a common chemotherapeutic and immunosuppressive drug whose investigation is important due to its biotransformation, toxic breakdown products, and potential for environmental pollution. The purpose of this review is ...
Başak Gökçe,Şeyma Rana Karakaş Başak Gökçe
Multidrug resistance remains a major challenge in cancer therapy, arising from complex adaptive mechanisms that enable tumor cells to survive pharmacological stress. Among these mechanisms, redox-regulating enzymes play a pivotal role by ma...
Hemn A H Barzani,Rebaz Anwar Omer,Khalamala Ibrahim Salih Barzani et al. Hemn A H Barzani et al.
Spironolactone (SPI) is a synthetic aldosterone antagonist steroid used to treat various conditions, including hypertension, heart failure, primary hyperaldosteronism, and androgen-related disorders. SPI undergoes extensive hepatic metaboli...
Dawei Wang Dawei Wang
The pursuit of precision in anesthesiology is persistently challenged by profound and unpredictable inter-patient variability in drug response. While pharmacogenomics has provided critical insights, a significant portion of this variability...
Mukul Shyam,Amrutha M,Niharika Kommoju et al. Mukul Shyam et al.
Doxorubicin, an anthracycline antibiotic extensively used in cancer treatment, is limited by its dose-dependent cardiotoxicity caused by oxidative stress, mitochondrial dysfunction, inflammation, and cardiomyocyte apoptosis-ultimately leadi...
Ahmed Qasim Abdulhussein,Diána Balogh-Weiser,Balázs Volk et al. Ahmed Qasim Abdulhussein et al.
Drug research, particularly in the early discovery phase, increasingly seeks cost-effective and reliable in vitro models to predict drug metabolism. Metalloporphyrins (MPs), due to their structural and functional resemblance to the heme gro...
Jack Uetrecht Jack Uetrecht
Idiosyncratic drug reactions (IDRs)represent a major risk for drug development. Current methods do not reliably predict IDR risk. There is strong evidence that most IDRs are immune-mediated. An adaptive immune response requires 2 signals: s...
Rasha A Guneidy Rasha A Guneidy
Chemoresistance remains a major barrier in cancer therapy, frequently resulting in treatment failure and reduced patient survival. This multifaceted phenomenon arises from the interplay of well-established mechanisms such as genetic mutatio...